Apixaban's Dominance in Modern Cardiovascular Therapy
The Shift from Warfarin to DOACs The landscape of anticoagulation has undergone a seismic shift over the last decade. For years, Vitamin K antagonists like Warfarin were the only option for patients requiring long-term blood thinning. However, the introduction of Direct Oral Anticoagulants (DOACs), with Apixaban at the forefront, has revolutionized patient outcomes. Apixaban’s predictable...
0 Comentários 0 Compartilhamentos 103 Visualizações 0 Anterior